TELMIKIND TRIO 12.5

About

Telmikind Trio 12.5 is a potent fixed-dose combination medication indicated for the treatment of essential hypertension, especially in cases where blood pressure remains inadequately controlled despite treatment with dual therapy or lower-dose triple regimens. This formulation combines Telmisartan, an angiotensin II receptor blocker (ARB), Amlodipine, a dihydropyridine calcium channel blocker (CCB), and Hydrochlorothiazide, a thiazide diuretic. Telmisartan effectively lowers blood pressure by blocking the AT1 receptors, preventing the vasoconstrictive actions of angiotensin II and reducing aldosterone release. Amlodipine complements this by relaxing vascular smooth muscle, primarily in peripheral arterioles, through the inhibition of calcium ion influx, leading to reduced peripheral vascular resistance. Hydrochlorothiazide, at a higher dose of 12.5mg, provides enhanced diuretic efficacy by increasing the renal excretion of sodium and water, thereby reducing plasma volume and contributing significantly to the antihypertensive effect. This comprehensive triple therapy targets distinct mechanisms of blood pressure regulation, ensuring powerful and sustained control for patients requiring more aggressive management.

Uses

• Treatment of moderate to severe essential hypertension.
• When blood pressure is inadequately controlled by other antihypertensive regimens.
• To reduce the risk of cardiovascular events in hypertensive patients.
• As a maintenance therapy for long-term blood pressure control.

Directions For Use

Take one tablet orally once daily, preferably at the same time each day, with or without food, or as advised by your healthcare provider.

Benefits

• Potent and sustained reduction in blood pressure.
• Synergistic action of three distinct antihypertensive agents.
• Effective for resistant hypertension cases.
• Convenient once-daily dosing improves adherence.
• Reduces the overall pill burden for patients.
• Offers comprehensive cardiovascular risk management.

Side Effects

• Dizziness, lightheadedness, or vertigo
• Headache
• Fatigue or weakness
• Peripheral edema
• Nausea, diarrhea, or constipation
• Dry cough (less common)
• Hypotension
• Electrolyte disturbances (e.g., hypokalemia, hyponatremia, hyperuricemia)
• Increased blood glucose levels
• Muscle cramps
• Palpitations
• Orthostatic hypotension

Safety Measures

• Alcohol - Concurrent use with alcohol may potentiate hypotensive effects and increase the risk of dizziness or syncope. Avoid or limit intake.
• Pregnancy - Absolutely contraindicated during the second and third trimesters of pregnancy due to significant risks of fetal injury and death.
• Breastfeeding - Not recommended during lactation as active ingredients may be excreted in breast milk, potentially affecting the nursing infant.
• Liver - Exercise caution in patients with impaired hepatic function; dose adjustments may be necessary, and liver enzymes should be monitored.
• Kidney - Contraindicated in anuric patients and used with extreme caution in severe renal impairment; monitor renal function and electrolytes closely.
• Lung - Generally safe, but patients with severe electrolyte imbalances from the diuretic component may experience respiratory distress.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.